Clay B. Thorp is a venture capitalist and entrepreneur. He co-founded Hatteras Venture Partners and has started eight life science companies.

What Clay can write

Writes checks of$3M to $30M+
Comes in atSeed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Hatteras Venture Partners writes $3M to $30M+ checks, larger than 93% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Hatteras Venture Partners.

Career

  1. Xanthon, Inc.
    1995
  2. Novalon Pharmaceutical Corporation · head of corporate development
  3. Hatteras Venture Partners · General Partner
    Now
  4. Synthematix, Inc. · CEO and Chairman
    2000-2005
  5. Ten63 Therapeutics · Chairman

Companies founded

Xanthon, Inc.Novalon Pharmaceutical CorporationHatteras Venture PartnersSynthematix, Inc.

Investments named in public bios

G1 Therapeutics (GTHX)HistoSonics, Inc.Rodin TherapeuticsVigil Neuro (VIGL)Clearside Biomedical (CLSD)Kymera Therapeutics (KYMR)AN2 Therapeutics (ANTX)Lysosomal Therapeutics, Inc.Asthmatx, Inc.PhaseBio Pharmaceuticals (PHAS)ArtusLabsSynthematix, Inc.

Focus

life sciencebiopharmaceuticalsmedical devicesdiagnosticsresearch informatics

Also at Hatteras Venture Partners

Partners like Clay

At firms with a similar stage, sector and check size.

Alert me when Hatteras Venture Partners is active

One email when Clay's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Clay B. Thorp?

Clay B. Thorp is a venture capitalist and entrepreneur. He co-founded Hatteras Venture Partners and has started eight life science companies.

How much does Clay B. Thorp invest?

Clay B. Thorp invests through Hatteras Venture Partners, which writes checks of $3M to $30M+ at seed, series a, series b.

How do I pitch Clay B. Thorp?

A warm intro from a founder Hatteras Venture Partners backed works best.

What did Clay B. Thorp do before Hatteras Venture Partners?

Xanthon, Inc.; head of corporate development at Novalon Pharmaceutical Corporation; CEO and Chairman at Synthematix, Inc.; Chairman at Ten63 Therapeutics.

Last updated 2026-10-15. Is this you? Ask for a correction.